A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

Kim Brøsen, Erik Skjelbo, Birgitte Buur Rasmussen et al. · Biochemical Pharmacology · 1993 · 372 citations

Medicine, Pharmacokinetics, Pharmacology +13

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

G Chouinard, L Annable, Réjean Fontaine et al. · Psychopharmacology · 1982 · 257 citations

Medicine, Pharmacology, Psychiatry +13

Some Biochemical Correlates of Panic Attacks with Agoraphobia and Their Response to a New Treatment

David V. Sheehan, James H. Coleman, David J. Greenblatt et al. · Journal of Clinical Psychopharmacology · 1984 · 160 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration

Randall B. Smith, Patricia D. Kroboth, James T. VanderLugt et al. · Psychopharmacology · 1984 · 116 citations

Medicine, Pharmacokinetics, Pharmacology +7

Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects

Randall B. Smith, Patricia D. Kroboth · Psychopharmacology · 1987 · 76 citations

Medicine, Pharmacokinetics, Pharmacology +12